Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • September 22, 2024

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Sep 19. doi: 10.1007/s12325-024-02961-3. Epub ahead of print. PMID: 39298075.

Tags: albuminuria, Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT-2i, Urinary albumin-to-creatinine ratio

The Impact of Renin-Angiotensin Aldosterone System Inhibitors in IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials

Rastogi A, Sarkar M, Kawai K, Munoz G, Simon L, Hwang M, Khalid M, Rhee C. The Impact of Renin-Angiotensin Aldosterone System Inhibitors in IgA[...]

Renal Outcomes of Triglyceride-Targeting Lipid-Lowering Therapies versus Statins in Patients with CKD

Naim MAAZ, Thomas F, Streja E, Davis RL, Kalantar-Zadeh K, Sumida K, Kovesdy CP. Renal Outcomes of Triglyceride-Targeting Lipid-Lowering Therapies versus Statins in Patients with[...]

Disparities in Kidney Transplantation Access and Outcomes among Native Hawaiians and Pacific Islanders in the United States

Noguchi K, Wong LL, Izutsu CH, Rhee CM, Lee LF. Disparities in Kidney Transplantation Access and Outcomes among Native Hawaiians and Pacific Islanders in the[...]